218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018)

Record Type:: Journal Article
Title:: 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018)
Main Title:: 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial
Authors:: Sonnenblick, A
Bailey, A
Uziely, B
Untch, M
Smith, I
Gianni, L
Baselga, J
Jackisch, C
Cameron, D
Bell, R
Zardavas, D
Al-Sakaff, N
Gelber, R
Dowsett, M
Leyland-jones, B
Piccart, M
de Azambuja, E
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 8
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Issue Display:: Volume 29, Issue 8 (2018)
Year:: 2018
Volume:: 29
Issue:: 8
Issue Sort Value:: 2018-0029-0008-0000
Page Start:
Page End:
Publication Date:: 2018-10-23
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy270.213 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12257.xml